[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Article in The Lancet Oncology (April 2024)
The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.
Article in The Lancet Oncology (April 2024)
Article in European Journal of Nuclear Medicine and Molecular Imaging (April 2024)
Article in Russian Journal of Oncology (December 2023)